Consistent Cara

throughout the day,

even at 6

pm

.

W hen Cara's A D H D sym ptom s are

consistently controlled, she can focus on her

lessons so others can see the child I see.

Vyvanse has been shown to provide significant

symptom control for up to 12 hours from

morning through homework and family time.

If yo u r ch ild w ith A D H D has tro u b le fo cusing,

a sk the doctor abo ut V yva n se .

1

-8 6 6 -6 3 0 -12 8 3 , w w w .vyvanse.com

Vyvanse™©

)

Vyvanse: Now 3 million prescriptions filled for ADHD.

IMPORTANT SAFETY INFORMATION

Vyvanse is indicated for the treatment of ADHD. Efficacy based on two

controlled trials in children aged 6 to 12 and one controlled trial in adults.

Tell the doctor about any heart conditions, including structural

abnorm alities, that you, your child, or a fam ily m em ber, m ay have.

Inform the doctor

immediately

if you or your child develops symptoms

that suggest heart problems, such as chest pain or fainting.

Vyvanse should not be taken if you or your child has advanced disease

of the blood vessels (arteriosclerosis); symptomatic heart disease;

moderate to severe high blood pressure; overactive thyroid gland

(hyperthyroidism); known allergy or unusual reactions to drugs called

sympathomimetic amines (for example, pseudoephedrine); seizures;

glaucoma; a history of problems with alcohol or drugs; agitated states;

taken a monoamine oxidase inhibitor (MAOI) within the last

14

days.

Tell the doctor

before

taking Vyvanse if you or your child is being

treated for or has symptoms of depression (sadness, worthlessness, or

hopelessness) or bipolar disorder; has abnormal thought or visions, hears

abnormal sounds, or has been diagnosed with psychosis; has had seizures

or abnormal EEGs; has or has had high blood pressure; exhibits aggressive

behavior or hostility. Tell the doctor

immediately

if you or your child

develops any of these conditions or symptoms while taking Vyvanse.

A buse of am phetam ines m ay lead to dependence. M isuse of

am phetam ine m ay cause sudden death and serious cardiovascular

adverse events. These events have also been reported rarely with

am phetam ine use.

Vyvanse was generally well tolerated in clinical studies. The most

common side effects reported in studies of Vyvanse were:

children

-

decreased appetite, difficulty falling asleep, stomachache, and irritability;

adult

- decreased appetite, difficulty falling asleep, and dry mouth.

Aggression, new abnormal thoughts/behaviors, mania, growth

suppression, worsening of motion or verbal tics,and Tourette's syndrome

have been associated with use of drugs of this type. Tell the doctor if

you or your child has blurred vision while taking Vyvanse.

Please see Patient Brief Sum m ary of Full Prescribing Inform ation

on the previous page.

TShire.

..your ADHD Support Company™

62009

Shire US lnc.VYV

00209

01/09

You are encouraged to report negative side effects of prescription drugs to the FDA. V isit www.fda.gov/m edwatch, or call 1-80 0 -FD A -10 88